New York Construction Report staff writer
Gov. Kathy Hochul announced plans on Tuesday for a $430 million New York BioGenesis Park, a cutting-edge cell and gene therapy innovation hub located in Lake Success.
Developed by the Albanese Organization, the ambitious 700,000-sq. ft. facility aims to position New York at the forefront of cell and gene therapy advancements. The state is investing $150 million in the project, which is expected to create thousands of high-skilled jobs and significantly contribute to the local economy.
“We’re not just advancing medical science; we’re creating a powerhouse that will drive our economy, generate thousands of high-skilled jobs, and bring hope to millions facing life-threatening diseases,” Hochul said. “This investment reaffirms our commitment to leading the future of healthcare and ensuring that the next medical breakthrough happens right here in New York.”
The project promises to be a global destination for life-saving therapies, with the initial phase set to generate approximately 830 full-time union construction jobs and an estimated 700 additional jobs in cell and gene therapy development, according to Russell Albanese, chairman of the Albanese Organization.
“The hub will further amplify and expand the economic engine that is the life sciences industry within New York State, and specifically Long Island,” Albanese said.
The BioGenesis Park project will be implemented in stages, featuring areas for public engagement, research, manufacturing, and collaboration. The first phase includes a 331,000-square-foot facility on Northwell Health’s campus in Lake Success.
Additionally, BioGenesis Park’s incubator will receive $50 million from Empire State Development’s Long Island Investment Fund, offering wet-lab space, shared equipment, and office facilities. This environment aims to provide cell and gene therapy companies with specialized equipment, mentoring, and financial guidance.
Future phases are expected to expand lab and office space even further. “Our goal is to establish this innovative cell and gene therapy hub on Long Island,” said Michael Dowling, president and CEO of Northwell Health. “The facility will be a game changer for physician-scientists, researchers, and innovative companies.”